- Regulation
- Technology
- Resources
Latest News
- Industry
-
Australia’s treasurer stops Cosette Pharmaceuticals’ $387.2m takeover bid of Mayne Pharma
The ups and downs of the proposed deal demonstrate the evolving landscape of compliance in the context of geopolitical tensions.
-
Report to US lawmakers flags impact of China pharma on US drug supply chain
The report urges Congress to bolster US pharmaceutical supply-chain resilience and reduce dependence on China.
-
Healthcare at a crossroads as America re-evaluates its approach
Significant developments in the healthcare sector are pulling at the integrity of the entire system.
-
Book review: Reimagining supply chains through shared progress
In a word where global supply chains define who benefits from progress, Power and Progress offers not just a warning, but a call “for reimagining a better future.”
-
Joe Stephenson and Paul Nightingale of Shoosmiths talk tariffs and tech
Joe (above left) and Paul discuss the likely impact of Trump’s tariff policy on the tech sector.
-
Strategic paths for pharma in a tariff-driven world
From short-term moves to long-term manufacturing bets, global reforms are still needed to stabilize the system.
-
Updated UK Modern Slavery Act guidance published
An in-depth look at the statement content guidance after the issue of the first significant update in 10 years.
-
How tariffs are reshaping the US pharmaceutical industry
President Trump’s broad 10% tariff push spares pharma for now, but global supply chains may not stay immune.